AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 254: R95-R101, 1988;
0363-6119/88 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vollmer, R. R.
Right arrow Articles by Fluharty, S. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vollmer, R. R.
Right arrow Articles by Fluharty, S. J.

AJP - Regulatory, Integrative and Comparative Physiology, Vol 254, Issue 1 95-101, Copyright © 1988 by American Physiological Society


ARTICLES

Angiotensin II facilitation of pressor responses to adrenal field stimulation in pithed rats

R. R. Vollmer, S. P. Corey and S. J. Fluharty
Department of Pharmacology-Physiology, University of Pittsburgh 15261.

The effects of angiotensin II on pressor responses to electrical field stimulation (1-32 Hz) of the adrenal gland were assessed in pithed male Sprague-Dawley rats. Stimulation elicited frequency-related pressor responses and increments in plasma catecholamines. Interruption of the renin-angiotensin system with the converting enzyme inhibitor captopril or the receptor antagonist saralasin significantly attenuated the pressor responses to adrenal stimulation and injected epinephrine to an equivalent extent. This observation, along with the finding that captopril did not alter the plasma catecholamine increments produced by adrenal stimulation, suggested that endogenously generated angiotensin II was not affecting adrenal catecholamine release. Instead angiotensin II appears to interact at the level of the vascular smooth muscle, because reinfusion of angiotensin II (20 ng.kg-1.min-1 iv) in captopril-treated animals restored responsiveness to stimulation and epinephrine. Infusion of vasopressin also restored pressor activity after captopril; therefore the interaction does not appear to be specific for angiotensin II but may depend on the background tone of the vascular smooth muscle. Moreover, decreasing blood pressure with sodium nitroprusside reversibly attenuated the pressor responses to both adrenal stimulation and epinephrine. The results suggest that endogenously formed angiotensin II facilitates the vasoconstrictor activity of epinephrine by increasing vascular tone.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online